MedTrace Logo

Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

NCT04684901 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-21

No results posted yet for this study

Summary

The primary objective of this study is to obtain evidence of the effectiveness of AlloWrap Amniotic Membrane in the reduction of soft tissue swelling in two-level ACDF procedures.

Conditions

  • Cervical Stenosis
  • Spondylolisthesis
  • Cervical Radiculopathy
  • Cervical Disc Disorder

Interventions

OTHER

AlloWrap® Amniotic Membrane

AlloWrap is a human amniotic membrane designed to provide a biologic barrier following surgical repair.

Sponsors & Collaborators

  • AlloSource

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2027-11-30
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684901 on ClinicalTrials.gov